Back to search

University of Crete (UOC)

Μελέτη της ανάπτυξης των καρδιακών βαλβίδων χρησιμοποιώντας το zebrafish ως οργανισμό μοντέλο: η επίδραση γενετικών και φαρμακολογικών παραγόντων

Abstract

dc:description

Ζebrafish is an excellent organism for modeling human diseases and is widely used for studies during the last two decades. It is amenable to forward and reverse genetic screens, and embryos can be obtained in large numbers, are transparent during early developmental stages. Most of the organs have simple morphology and are amenable to study at larval stages. During a forward genetic screen we identified two novel mutant lines. The first is the s457 line which we used as a model for studying intracardiac flow dynamics in respect to the development of the cardiac valves and the second one is the s266 line which is the first zebrafish CMT2D model. Here, we describe a novel zebrafish model of valve defects. We identified a novel mutant allele of southpaw, a nodal related gene involved in the early establishment of left-right asymmetry, which exhibits randomized heart and endoderm positioning. We show that unlooped hearts have defects in cardiac valve maturation, contrary to mutant hearts that are properly looped or exhibit situs inversus. spaw mutants have no detectable defects in myocardial function. Only the relative position of the two chambers is altered in these mutants, affecting the geometry of the heart and therefore the intracardiac flow pattern. We proved that that intracardiac flow dynamics regulate valve morphogenesis, independently of myocardial contractility.As mentioned above, in this study we also described the first Charcot-Marie-Tooth type 2D zebrafish model. CMT disease is a genetically heterogeneous group of peripheral neuropathies. Mutations in several aminoacyl tRNA synthetase genes have been implicated in inherited CMT disease. There are 12 reported CMT-causing mutations dispersed throughout the primary sequence of the human Glycyl t-RNA synthetase. While there is strong genetic evidence linking GARS mutations to CMT disease, the molecular pathology that underlies the progression of the neuromuscular phenotype is still not fully understood. During a forward genetic screen, we identified a zebrafish allele of gars. Homozygous mutant embryos carry a C->A transversion, leading to a non-conservative substitution within the gars gene that changes a threonine to a lysine. We show that the neuromuscular phenotype observed in animals homozygous for T130K is due to a loss of dimerization of the mutated protein and the loss of function and dimer deficient G240R mutant protein is unable to rescue the above phenotype. In addition, G526R Gars dimerizes with the remaining wild-type protein in animals heterozygous for the T130K GARS and reduces the function enough, to elicit a neuromuscular phenotype. Our data indicate that dimerization is required for the dominant neurotoxicity of disease-associated GARS mutations and provide a rapid, tractable model for studying newly identified variants for a role in human disease.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Malissovas, Nikolaos
  • Μαλισσόβας, Νικόλαος

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • BY_NC
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37643

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Malissovas, Nikolaos; Μαλισσόβας, Νικόλαος. Μελέτη της ανάπτυξης των καρδιακών βαλβίδων χρησιμοποιώντας το zebrafish ως οργανισμό μοντέλο: η επίδραση γενετικών και φαρμακολογικών παραγόντων. University of Crete (UOC), 2016. http://hdl.handle.net/10442/hedi/37643